Testing effectiveness (Phase 2)Study completedNCT01575860What this trial is testingMaintenance Lenalidomide in LymphomaWho this might be right forLymphoma Abramson Cancer Center at Penn Medicine 8
Early research (Phase 1)Looking for participantsNCT07121946What this trial is testingThis is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma Refractory/ RelapsedDLBCL - Diffuse Large B Cell LymphomaMantle Cell Lymphoma (MCL)+2 more LTZ Therapeutics, Inc. 42
Not applicableUnknownNCT04587388What this trial is testingTowards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae RegistryWho this might be right forFollicular LymphomaRelapsed/Refractory Follicular Lymphoma European Hematology Association - Lymphoma Group 500
Testing effectiveness (Phase 2)Ended earlyNCT00017069What this trial is testingArsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm CTI BioPharma
Testing effectiveness (Phase 2)Study completedNCT00812669What this trial is testingCLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7Who this might be right forLeukemia Cancer Trials Ireland 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT04536805What this trial is testingRelapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by MetforminWho this might be right forProstate Cancer Institut Cancerologie de l'Ouest 44
Early research (Phase 1)Looking for participantsNCT05366179What this trial is testingAutologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3TcWho this might be right forGlioblastoma Multiforme UNC Lineberger Comprehensive Cancer Center 36
Early research (Phase 1)Study completedNCT02561962What this trial is testingStudy in Subjects With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Amgen 42
Testing effectiveness (Phase 2)Ended earlyNCT01636388What this trial is testingAllogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins LymphomaWho this might be right forHodgkins Lymphoma New York Medical College 2
Testing effectiveness (Phase 2)Looking for participantsNCT04322383What this trial is testingBinimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and VariantWho this might be right forHairy Cell Leukemia National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT04240002What this trial is testingGilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia (AML)Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD) Astellas Pharma Global Development, Inc. 9
Early research (Phase 1)Ended earlyNCT00313053What this trial is testingStudy of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic LeukemiaWho this might be right forLeukemia, Lymphocytic, AcuteLeukemiaAcute Lymphoid Leukemia (ALL) Clare Twist 4
Early research (Phase 1)Looking for participantsNCT06830031What this trial is testingClinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell LymphomaWho this might be right forDiffuse Large B-cell-lymphomaDLBCL, Nos Genetic SubtypesFollicular Lymphoma Grade 3B+3 more Shanghai Exuma Biotechnology Ltd. 18
Early research (Phase 1)Study completedNCT03870945What this trial is testingSafety of MB-CART2019.1 in Lymphoma Patients (MB-CART2019.1 Lymphoma / DALY 1)Who this might be right forB-cell Non Hodgkin Lymphoma Miltenyi Biomedicine GmbH 12
Testing effectiveness (Phase 2)UnknownNCT00360945What this trial is testingCisplatin and Temozolomide in Treating Young Patients With Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Children's Cancer and Leukaemia Group 87
Early research (Phase 1)Study completedNCT01830777What this trial is testingBrentuximab Vedotin + Re-induction Chemotherapy for AMLWho this might be right forAcute Myelogenous Leukemia Massachusetts General Hospital 22
Testing effectiveness (Phase 2)UnknownNCT04877275What this trial is testingATG-010(Selinexor) in Combination With Chemotherapy in RRMMWho this might be right forMultiple Myeloma Chunyan Sun, MD 50
Early research (Phase 1)Study completedNCT01122875What this trial is testingThe Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple MyelomaWho this might be right forMultiple Myeloma Genentech, Inc. 14
Not applicableUnknownNCT05126875What this trial is testingRe-TREAT: Re-irradiation for Relapsed Brain MetastasesWho this might be right forCancerBrain Metastases, Adult Rigshospitalet, Denmark 44
Testing effectiveness (Phase 2)Ended earlyNCT03093831What this trial is testingPhase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone LymphomaWho this might be right forLymphoma, B-Cell, Marginal Zone National Cancer Centre, Singapore 5